Efficacy of interferon-beta plus ribavirin combination treatment on the development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C-Reference-Cited by-同舟云学术

Efficacy of interferon-beta plus ribavirin combination treatment on the development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C

Published:2015-09-02 Issue:3 Volume:46 Page:E174-E180
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Ikezaki Hiroaki¹²,Nomura Hideyuki³,Furusyo Norihiro¹²,Ogawa Eiichi¹²,Kajiwara Eiji⁴,Takahashi Kazuhiro⁵,Kawano Akira⁶,Maruyama Toshihiro⁶,Tanabe Yuichi⁷,Satoh Takeaki⁸,Nakamuta Makoto⁹,Kotoh Kazuhiro¹⁰,Azuma Koichi¹¹,Dohmen Kazufumi¹²,Shimoda Shinji¹³,Hayashi Jun¹⁴,

Affiliation:

1. Department of General Internal Medicine; Kyushu University Hospital

2. Department of Environmental Medicine and Infectious Disease, Graduate School of Medical Science; Kyushu University; Fukuoka City Japan

3. The Center for Liver Disease; Shin-Kokura Hospital; Kitakyushu City Japan

4. Department of Internal Medicine; Steel Memorial Yawata Hospital; Kitakyushu City Japan

5. Department of Medicine; Hamanomachi Hospital; Fukuoka City Japan

6. Department of Medicine; Kitakyushu Municipal Medical Center; Kitakyushu City Japan

7. Department of Medicine; Fukuoka City Hospital; Fukuoka City Japan

8. Center for Liver Disease; National Hospital Organization Kokura Medical Center; Kitakyushu City Japan

9. Department of Gastroenterology; Kyushu Medical Center, National Hospital Organization; Fukuoka City Japan

10. Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences; Kyushu University; Fukuoka City Japan

11. Department of Medicine; Kyushu Central Hospital; Fukuoka City Japan

12. Department of Internal Medicine; Chihaya Hospital; Fukuoka City Japan

13. Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences; Kyushu University; Fukuoka City Japan

14. Kyushu General Internal Medicine Center; Hara-Doi Hospital; Fukuoka City Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12555/fullpdf

Reference31 articles.

1. Impact of hepatitis C virus eradication on hepatocellular carcinogenesis;Darrick;Cancer,2015

2. Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection;Kanwal;Gastroenterology,2011

3. AASLD Recommendations for Testing, Managing, and Treating Hepatitis C http://www.hcvguidelines.org

4. EASL clinical practice guidelines: management of hepatitis C virus infection;European Association for Study of the Liver;J Hepatol,2014

5. Characterization of virologic escape in hepatitis C virus genotype 1b patients treated with the direct-acting antivirals daclatasvir and asunaprevir;Karino;J Hepatol,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence and risk factors of hepatocellular carcinoma change over time in patients with hepatitis C virus infection who achieved sustained virologic response;Hepatology Research;2019-02-06

2. β-defensin 1 expression in HCV infected liver/liver cancer: an important role in protecting HCV progression and liver cancer development;Scientific Reports;2017-10-17

3. Impact of antiviral therapy on hepatocellular carcinoma and mortality in patients with chronic hepatitis C: systematic review and meta-analysis;BMC Gastroenterology;2017-04-04

4. The impact of hepatitis C virus outside the liver: Evidence from Asia;Liver International;2016-11-10